Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients
Open Access
- 23 August 2010
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (5), 591-597
- https://doi.org/10.1016/j.bbmt.2010.08.007
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Hematopoietic Stem Cell TransplantationA Global PerspectiveJAMA, 2010
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipientsBlood, 2010
- A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graftversushost disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)British Journal of Haematology, 2009
- How I treat EBV lymphoproliferationBlood, 2009
- Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemiaHaematologica, 2009
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationBlood, 2009
- Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity ConditioningJournal of Clinical Oncology, 2008
- Epstein–Barr virus, rapamycin, and host immune responsesCurrent Opinion in Organ Transplantation, 2008
- Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell ImmunityTransplantation and Cellular Therapy, 2008
- Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDSBlood, 2006